Skip to main content
NCBI home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 1994 Oct;51(10):669–673. doi: 10.1136/oem.51.10.669

Comparison of measures of lead exposure, dose, and chelatable lead burden after provocative chelation in organolead workers.

B S Schwartz 1, M P McGrail 1, W Stewart 1, T Pluth 1
PMCID: PMC1128075  PMID: 8000491

Abstract

OBJECTIVES--To describe 6 h urinary lead excretion (6 h PbU) after 1 g intravenous ethylene diamine tetraacetic acid (EDTA) in organolead manufacturing workers with mixed exposure to organic and inorganic lead; to determine the predictors of lead excretion (PbU); and to determine the extent to which internal lead stores and ongoing external exposure govern blood concentrations of lead (PbB). METHODS--A case series of 21 active workers were studied. Personal industrial hygiene data, grouped by 29 exposure zones, in combination with personal interviews about work location and times were used to derive several measures of recent and cumulative exposure to organic and inorganic lead. The average exposure intensities assigned to the 29 zones ranged from 4 to 119 micrograms/m3 (0.02-0.57 mumol/m3 as lead) for organic lead and from 1 to 56 micrograms/m3 (0.004-0.27 mumol/m3) for inorganic lead. RESULTS--After controlling for age, 6 h PbU was significantly and positively correlated with summary measures of PbB--for example, lifetime peak PbB, time weighted PbB--and zinc protoporphyrin concentrations--for example, lifetime peak zinc protoporphyrin, time weighted zinc protoporphyrin--but not with measures of estimated external exposure--for example, duration of exposure and cumulative exposure to inorganic or organic lead. Among workers with higher chelatable lead burdens (6 h PbU > or = 212.4 micrograms (1.03 mumol) divided at the median), there was no apparent relation between recent inorganic lead exposure and PbB at the time of chelation. Among workers with lower chelatable lead burdens (6 h PbU < 212.4 micrograms (1.03 mumol) however, there was a significant relation between exposure and effect between recent exposure to inorganic lead and PbBs. CONCLUSION--These findings are consistent with the concept of physiological dampening. The high chelatable lead burden, a source of internal exposure, dampens the effect of external exposure on PbBs. The data suggest that in organolead workers with high chelatable lead burdens, PbBs may be more influenced by internal lead stores than by variations in airborne exposure to organic and inorganic lead.

Full text

PDF
669

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai F. Determination of triethyllead, diethyllead and inorganic lead in urine by atomic absorption spectrometry. Ind Health. 1986;24(3):139–150. doi: 10.2486/indhealth.24.139. [DOI] [PubMed] [Google Scholar]
  2. BOYD P. R., HENDERSON I. N., WALKER G. The treatment of tetraethyl lead poisoning. Lancet. 1957 Jan 26;272(6961):181–185. doi: 10.1016/s0140-6736(57)92487-x. [DOI] [PubMed] [Google Scholar]
  3. Barry P. S., Mossman D. B. Lead concentrations in human tissues. Br J Ind Med. 1970 Oct;27(4):339–351. doi: 10.1136/oem.27.4.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bolanowska W. Distribution and excretion of triethyllead in rats. Br J Ind Med. 1968 Jul;25(3):203–208. doi: 10.1136/oem.25.3.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Christoffersson J. O., Ahlgren L., Schütz A., Skerfving S., Mattsson S. Decrease of skeletal lead levels in man after end of occupational exposure. Arch Environ Health. 1986 Sep-Oct;41(5):312–318. doi: 10.1080/00039896.1986.9936703. [DOI] [PubMed] [Google Scholar]
  6. Corsi G., Bartolucci G. B. Biological monitoring of workers with past lead exposure. Biochemical findings. Scand J Work Environ Health. 1982 Dec;8(4):260–266. doi: 10.5271/sjweh.2468. [DOI] [PubMed] [Google Scholar]
  7. Ferreira da Silva D., Schröder U., Diehl H. Metabolism of tetraorganolead compounds by rat-liver microsomal mono-oxygenase. II. Enzymic dealkylation of tetraethyl lead. Xenobiotica. 1983 Oct;13(10):583–590. doi: 10.3109/00498258309052217. [DOI] [PubMed] [Google Scholar]
  8. Gething J. Tetramethyl lead absorption: a report of human exposure to a high level of tetramethyl lead. Br J Ind Med. 1975 Nov;32(4):329–333. doi: 10.1136/oem.32.4.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Grandjean P., Nielsen T. Organolead compounds: environmental health aspects. Residue Rev. 1979;72:97–148. doi: 10.1007/978-1-4612-6214-5_4. [DOI] [PubMed] [Google Scholar]
  10. Gross S. B., Pfitzer E. A., Yeager D. W., Kehoe R. A. Lead in human tissues. Toxicol Appl Pharmacol. 1975 Jun;32(3):638–651. doi: 10.1016/0041-008x(75)90127-1. [DOI] [PubMed] [Google Scholar]
  11. Hansen J. P., Døssing M., Paulev P. E. Chelatable lead body burden (by calcium-disodium EDTA) and blood lead concentration in man. J Occup Med. 1981 Jan;23(1):39–43. doi: 10.1097/00043764-198101000-00017. [DOI] [PubMed] [Google Scholar]
  12. Hansen K. S., Sharp F. R. Gasoline sniffing, lead poisoning, and myoclonus. JAMA. 1978 Sep 22;240(13):1375–1376. [PubMed] [Google Scholar]
  13. Hayakawa K. Microdetermination and dynamic aspects of in vivo alkyl lead compounds. II. Studies on the dynamic aspects of alkyl lead compounds in vivo. Nihon Eiseigaku Zasshi. 1972 Feb;26(6):526–535. doi: 10.1265/jjh.26.526. [DOI] [PubMed] [Google Scholar]
  14. Hryhorczuk D. O., Rabinowitz M. B., Hessl S. M., Hoffman D., Hogan M. M., Mallin K., Finch H., Orris P., Berman E. Elimination kinetics of blood lead in workers with chronic lead intoxication. Am J Ind Med. 1985;8(1):33–42. doi: 10.1002/ajim.4700080105. [DOI] [PubMed] [Google Scholar]
  15. Hu H., Pepper L., Goldman R. Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone. Am J Ind Med. 1991;20(6):723–735. doi: 10.1002/ajim.4700200603. [DOI] [PubMed] [Google Scholar]
  16. Marcus A. H. The body burden of lead: comparison of mathematical models for accumulation. Environ Res. 1979 Jun;19(1):79–90. doi: 10.1016/0013-9351(79)90036-7. [DOI] [PubMed] [Google Scholar]
  17. Rabinowitz M. B., Wetherill G. W., Kopple J. D. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest. 1976 Aug;58(2):260–270. doi: 10.1172/JCI108467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rappaport S. M. Assessment of long-term exposures to toxic substances in air. Ann Occup Hyg. 1991 Feb;35(1):61–121. doi: 10.1093/annhyg/35.1.61. [DOI] [PubMed] [Google Scholar]
  19. Robinson R. O. Tetraethyl lead poisoning from gasoline sniffing. JAMA. 1978 Sep 22;240(13):1373–1374. [PubMed] [Google Scholar]
  20. Schwartz B. S., Bolla K. I., Stewart W., Ford D. P., Agnew J., Frumkin H. Decrements in neurobehavioral performance associated with mixed exposure to organic and inorganic lead. Am J Epidemiol. 1993 May 1;137(9):1006–1021. doi: 10.1093/oxfordjournals.aje.a116757. [DOI] [PubMed] [Google Scholar]
  21. Sokas R. K., Atleson J., Keogh J. P. Shortened forms of provocative lead chelation. J Occup Med. 1988 May;30(5):420–424. doi: 10.1097/00043764-198805000-00008. [DOI] [PubMed] [Google Scholar]
  22. Tell I., Somervaille L. J., Nilsson U., Bensryd I., Schütz A., Chettle D. R., Scott M. C., Skerfving S. Chelated lead and bone lead. Scand J Work Environ Health. 1992 Apr;18(2):113–119. doi: 10.5271/sjweh.1603. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES